Turpie AGG - Search Results

1

Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE.

Weitz JI, Haas S, Ageno W, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Nielsen JD, Kayani G, Farjat AE, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK; GARFIELD-VTE investigators. Weitz JI, et al. Among authors: turpie agg. J Thromb Thrombolysis. 2020 Aug;50(2):267-277. doi: 10.1007/s11239-020-02180-x. J Thromb Thrombolysis. 2020. PMID: 32583306

2

New advances in the management of acute coronary syndromes: 4. Low-molecular-weight heparins.

Ageno W, Turpie AG. Ageno W, et al. CMAJ. 2002 Apr 2;166(7):919-24. CMAJ. 2002. PMID: 11949991 Free PMC article. Review. No abstract available.

3

The safety of antithrombotic therapy during pregnancy.

Ageno W, Crotti S, Turpie AG. Ageno W, et al. Expert Opin Drug Saf. 2004 Mar;3(2):113-8. doi: 10.1517/eods.3.2.113.27343. Expert Opin Drug Saf. 2004. PMID: 15006717 Review.

4

Thromboprophylaxis in medical patients: the role of low-molecular-weight heparin.

Turpie AG, Norris TM. Turpie AG, et al. Thromb Haemost. 2004 Jul;92(1):3-12. doi: 10.1160/TH03-07-0469. Thromb Haemost. 2004. PMID: 15213839 Review.

5

Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.

Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ; PREVENT Medical Thromboprophylaxis Study Group. Leizorovicz A, et al. Circulation. 2004 Aug 17;110(7):874-9. doi: 10.1161/01.CIR.0000138928.83266.24. Epub 2004 Aug 2. Circulation. 2004. PMID: 15289368 Clinical Trial.

6

Prevention of venous thromboembolism among hospitalized medical patients.

Goldhaber SZ, Turpie AG. Goldhaber SZ, et al. Circulation. 2005 Jan 4;111(1):e1-3. doi: 10.1161/01.CIR.0000150393.51958.54. Circulation. 2005. PMID: 15630031 Review. No abstract available.

7

Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients.

Vaitkus PT, Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Goldhaber SZ; PREVENT Medical Thromboprophylaxis Study Group. Vaitkus PT, et al. Thromb Haemost. 2005 Jan;93(1):76-9. doi: 10.1160/TH04-05-0323. Thromb Haemost. 2005. PMID: 15630494

8

Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: a subgroup analysis of the PREVENT trial.

Kucher N, Leizorovicz A, Vaitkus PT, Cohen AT, Turpie AG, Olsson CG, Goldhaber SZ. Kucher N, et al. Arch Intern Med. 2005 Feb 14;165(3):341-5. doi: 10.1001/archinte.165.3.341. Arch Intern Med. 2005. PMID: 15710801

9

What's new for DVT prophylaxis for the medically ill.

Ageno W, Turpie AG. Ageno W, et al. Dis Mon. 2005 Feb-Mar;51(2-3):194-9. doi: 10.1016/j.disamonth.2005.03.015. Dis Mon. 2005. PMID: 15900272 No abstract available.

10

Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients.

Cohen AT, Alikhan R, Arcelus JI, Bergmann JF, Haas S, Merli GJ, Spyropoulos AC, Tapson VF, Turpie AG. Cohen AT, et al. Thromb Haemost. 2005 Oct;94(4):750-9. Thromb Haemost. 2005. PMID: 16270626 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters